• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Turning Physics into a Diagnostic Signal for Bladder Cancer

Turning Physics into a Diagnostic Signal for Bladder Cancer

by Bree Foster, PhD | Mar 13, 2026 | Clinical Diagnostics Insider, Emerging Tests-dtet

A physics-based urine test shows early promise in detecting bladder cancer recurrence without invasive procedures

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Diagnostics Pipeline: NeuroQure Launches Test for Early Autism Diagnosis

Diagnostics Pipeline: NeuroQure Launches Test for Early Autism Diagnosis

by Ron Shinkman | Mar 11, 2026 | Clinical Diagnostics Insider, Emerging Tests-dtet, Testing Trends-dtet

The skin-based test can be used on children as young as two days old

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
AI-Designed Molecular Sensors Could Transform Early Cancer Detection

AI-Designed Molecular Sensors Could Transform Early Cancer Detection

by Janette Wider | Jan 28, 2026 | Clinical Diagnostics Insider, Testing Trends-dtet

Advances could signal changes for clinical laboratories and at-home testing

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Diagnostics Pipeline: MyOme and Artera Launch New Tests for Prostate Cancer Risk

Diagnostics Pipeline: MyOme and Artera Launch New Tests for Prostate Cancer Risk

by Ron Shinkman | Jan 26, 2026 | Clinical Diagnostics Insider, Testing Trends-dtet

The two assays identify threats prior to prostate cancer being diagnosed and after it has undergone extensive treatment, respectively

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Dx Deals: Seeking Expanded MRD Testing, Natera Acquires Foresight Diagnostics in $450M Deal

Dx Deals: Seeking Expanded MRD Testing, Natera Acquires Foresight Diagnostics in $450M Deal

by Ron Shinkman | Jan 26, 2026 | Deals-lir, Essential, Lab Industry Advisor

Agreement is part of the Natera’s aggressive growth model as it strives to turn a profit

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries

Log In

Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2026 G2Intelligence.com